{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2026-07-30", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "safetyreportversion": "1", "safetyreportid": "19740712", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20211014", "reporttype": "1", "serious": "2", "receivedateformat": "102", "receivedate": "20210824", "receiptdateformat": "102", "receiptdate": "20210824", "fulfillexpeditecriteria": "2", "companynumb": "US-GW PHARMA-202108USGW04028", "duplicate": "1", "reportduplicate": { "duplicatesource": "GW PHARMA", "duplicatenumb": "US-GW PHARMA-202108USGW04028" }, "primarysource": { "reportercountry": "US", "qualification": "3" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "reaction": [ { "reactionmeddraversionpt": "24.0", "reactionmeddrapt": "Product taste abnormal", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "24.0", "reactionmeddrapt": "Vomiting", "reactionoutcome": "6" } ], "drug": [ { "drugcharacterization": "2", "medicinalproduct": "LAMICTAL", "drugdosagetext": "UNK", "drugadministrationroute": "065", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "activesubstance": { "activesubstancename": "LAMOTRIGINE" }, "openfda": { "application_number": [ "NDA020764", "NDA020241", "NDA022251", "NDA022115" ], "brand_name": [ "LAMICTAL", "LAMICTAL ODT", "LAMICTAL XR" ], "generic_name": [ "LAMOTRIGINE" ], "manufacturer_name": [ "GlaxoSmithKline LLC" ], "product_ndc": [ "0173-0526", "0173-0633", "0173-0642", "0173-0643", "0173-0644", "0173-0699", "0173-0527", "0173-0772", "0173-0774", "0173-0776", "0173-0777", "0173-0594", "0173-0779", "0173-0780", "0173-0778", "0173-0817", "0173-0754", "0173-0755", "0173-0756", "0173-0757", "0173-0758", "0173-0760", "0173-0759", "0173-0761", "0173-0781" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "LAMOTRIGINE" ], "rxcui": [ "103968", "105018", "105019", "108782", "198427", "198428", "198429", "198430", "201239", "201240", "206201", "252478", "252479", "282401", "311264", "311265", "349010", "542426", "751139", "751563", "753451", "795772", "795774", "795778", "849049", "849050", "849051", "849052", "851748", "851749", "851750", "851751", "851752", "851753", "850087", "850091", "900145", "900156", "900157", "900164", "900165", "900169", "900865", "900866", "900890", "900891", "900983", "900984", "1098608", "1098610", "1146690", "1146692" ], "spl_id": [ "076c76e0-4a5e-491b-ba85-de2dd757b436", "d0cca76f-809f-4db8-a468-619a217debc1" ], "spl_set_id": [ "d7e3572d-56fe-4727-2bb4-013ccca22678", "3e2c9a35-6a39-41d7-ad84-3c0bb8894b09" ], "package_ndc": [ "0173-0633-02", "0173-0633-10", "0173-0642-55", "0173-0643-60", "0173-0644-60", "0173-0699-02", "0173-0699-00", "0173-0526-00", "0173-0527-00", "0173-0772-02", "0173-0774-02", "0173-0776-02", "0173-0777-02", "0173-0594-02", "0173-0779-00", "0173-0780-00", "0173-0778-00", "0173-0817-28", "0173-0754-00", "0173-0755-00", "0173-0756-00", "0173-0757-00", "0173-0758-00", "0173-0760-00", "0173-0759-00", "0173-0761-00", "0173-0781-00" ], "nui": [ "N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191" ], "pharm_class_epc": [ "Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]" ], "pharm_class_pe": [ "Decreased Central Nervous System Disorganized Electrical Activity [PE]" ], "pharm_class_moa": [ "Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]" ], "unii": [ "U3H27498KS" ] } }, { "drugcharacterization": "2", "medicinalproduct": "BANZEL", "drugdosagetext": "UNK", "drugadministrationroute": "065", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "activesubstance": { "activesubstancename": "RUFINAMIDE" }, "openfda": { "application_number": [ "NDA021911", "NDA201367" ], "brand_name": [ "BANZEL" ], "generic_name": [ "RUFINAMIDE" ], "manufacturer_name": [ "Eisai Inc." ], "product_ndc": [ "62856-582", "62856-583", "62856-584" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "RUFINAMIDE" ], "rxcui": [ "824295", "824299", "824301", "824303", "1092357", "1092360" ], "spl_id": [ "0cc6f13a-0289-45f7-980e-3196d7489d75" ], "spl_set_id": [ "0a3fa925-1abd-458a-bd57-4ae780a1ef2d" ], "package_ndc": [ "62856-582-52", "62856-582-04", "62856-583-14", "62856-583-52", "62856-584-46" ], "unii": [ "WFW942PR79" ] } }, { "drugcharacterization": "2", "medicinalproduct": "ONFI", "drugdosagetext": "UNK", "drugadministrationroute": "065", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "activesubstance": { "activesubstancename": "CLOBAZAM" }, "openfda": { "application_number": [ "NDA203993", "NDA202067" ], "brand_name": [ "ONFI" ], "generic_name": [ "CLOBAZAM" ], "manufacturer_name": [ "Lundbeck Pharmaceuticals LLC" ], "product_ndc": [ "67386-313", "67386-314", "67386-315" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "CLOBAZAM" ], "rxcui": [ "199450", "246172", "1191056", "1191058", "1366192", "1366196" ], "spl_id": [ "68dbe31c-2dbe-49ad-8b2e-2cf1b8521167" ], "spl_set_id": [ "de03bd69-2dca-459c-93b4-541fd3e9571c" ], "package_ndc": [ "67386-314-01", "67386-315-01", "67386-313-21" ], "nui": [ "N0000175694", "M0002356", "N0000182137", "N0000185506" ], "pharm_class_epc": [ "Benzodiazepine [EPC]" ], "pharm_class_cs": [ "Benzodiazepines [CS]" ], "pharm_class_moa": [ "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]" ], "unii": [ "2MRO291B4U" ] } }, { "drugcharacterization": "1", "medicinalproduct": "EPIDIOLEX", "drugdosagetext": "1040 MILLIGRAM", "drugdosageform": "ORAL SOLUTION", "drugadministrationroute": "048", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "drugstartdateformat": "102", "drugstartdate": "20190309", "actiondrug": "5", "drugadditional": "3", "activesubstance": { "activesubstancename": "CANNABIDIOL" }, "openfda": { "application_number": [ "NDA210365" ], "brand_name": [ "EPIDIOLEX" ], "generic_name": [ "CANNABIDIOL" ], "manufacturer_name": [ "Jazz Pharmaceuticals, Inc." ], "product_ndc": [ "70127-100" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "CANNABIDIOL" ], "rxcui": [ "2058900", "2058906" ], "spl_id": [ "1eb7ac65-8df5-4a4a-9156-802cfaa92b06" ], "spl_set_id": [ "8bf27097-4870-43fb-94f0-f3d0871d1eec" ], "package_ndc": [ "70127-100-01", "70127-100-10", "70127-100-06", "70127-100-60" ], "nui": [ "M0003267", "N0000187062", "N0000185504", "N0000182140", "N0000191278", "N0000191273", "N0000182138", "N0000182139", "N0000187064" ], "pharm_class_cs": [ "Cannabinoids [CS]" ], "pharm_class_moa": [ "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "UGT1A9 Inhibitors [MoA]", "UGT2B7 Inhibitors [MoA]", "Cytochrome P450 1A2 Inhibitors [MoA]", "Cytochrome P450 2B6 Inhibitors [MoA]", "Cytochrome P450 2B6 Inducers [MoA]" ], "unii": [ "19GBJ60SN5" ] } } ] } } ] }